Sienna Gestion lessened its stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 15.4% in the fourth quarter, Holdings Channel reports. The institutional investor owned 44,258 shares of the medical research company’s stock after selling 8,031 shares during the period. Sienna Gestion’s holdings in Agilent Technologies were worth $6,060,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in A. Core Wealth Advisors LLC bought a new position in Agilent Technologies during the 4th quarter valued at approximately $26,000. Board of the Pension Protection Fund bought a new stake in shares of Agilent Technologies in the 4th quarter worth $27,000. Navalign LLC bought a new stake in shares of Agilent Technologies in the 4th quarter worth $27,000. Entrust Financial LLC bought a new stake in shares of Agilent Technologies in the 4th quarter worth $31,000. Finally, Torren Management LLC bought a new stake in shares of Agilent Technologies in the 4th quarter worth $32,000.
Agilent Technologies Price Performance
NYSE A opened at $130.52 on Tuesday. The company has a market capitalization of $36.86 billion, a PE ratio of 26.21, a price-to-earnings-growth ratio of 2.31 and a beta of 1.26. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The business’s fifty day moving average is $120.55 and its 200 day moving average is $127.49. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $160.27.
Agilent Technologies Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be issued a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s payout ratio is 20.48%.
Analyst Ratings Changes
A number of research firms have commented on A. Piper Sandler began coverage on Agilent Technologies in a report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 target price for the company. UBS Group reduced their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Morgan Stanley reduced their target price on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Robert W. Baird lifted their target price on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a report on Tuesday, May 26th. Finally, Barclays lifted their price objective on Agilent Technologies from $140.00 to $145.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Agilent Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $160.93.
Check Out Our Latest Report on Agilent Technologies
About Agilent Technologies
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
See Also
- Five stocks we like better than Agilent Technologies
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
